Industry Digs Into Specifics Of CMS Proposal For Covering Clinical Trial Costs
This article was originally published in The Gray Sheet
Executive Summary
Device industry representatives say CMS' latest proposed revision of its policy for covering certain clinical trial costs is a significant improvement over the previous proposal, but claim some specific requirements would be too burdensome on manufacturers